Purine Nucleoside Phosphorylase Targeted by Annexin V to Breast Cancer Vasculature for Enzyme Prodrug Therapy-Reference-Cited by-同舟云学术

Purine Nucleoside Phosphorylase Targeted by Annexin V to Breast Cancer Vasculature for Enzyme Prodrug Therapy

Published:2013-10-03 Issue:10 Volume:8 Page:e76403
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Krais John J.,De Crescenzo Olivier,Harrison Roger G.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference39 articles.

1. Oral fludarabine therapy in chronic lymphocytic leukemia–increased convenience;MA Boogaerts;Hematol J,2004

2. Phase I clinical trial of fludarabine phosphate (F-ara-AMP);ES Casper;Cancer Chemother Pharmacol,1985

3. Cytotoxic activity of 2-Fluoro-ara-AMP and 2-Fluoro-ara-AMP-loaded erythrocytes against human breast carcinoma cell lines;F Pierige;Int J Oncol,2010

4. Ocular toxicity of fludarabine: a purine analog;X Ding;Expert Rev Ophthalmol,2008

5. Phase I clinical trials with fludarabine phosphate;DD Von Hoff;Semin Oncol,1990

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, Synthesis and Anti-Melanoma Activity of Novel Annexin V Derivative with β3-Integrin Affinity;International Journal of Molecular Sciences;2023-07-05

2. Computational, in vitro and radiation-based in vivo studies on acetamide quinazolinone derivatives as new proposed purine nucleoside phosphorylase inhibitors for breast cancer;European Journal of Medicinal Chemistry;2023-02

3. Evaluating antitumor activity of Escherichia coli purine nucleoside phosphorylase against head and neck patient‐derived xenografts;Cancer Reports;2022-10-17

4. Annexin A5 as a targeting agent for cancer treatment;Cancer Letters;2022-10

5. Microbial Enzymes used in Prodrug Activation for Cancer Therapy: Insights and Future Perspectives;Current Protein & Peptide Science;2021-12-07